1. Home
  2. GLP vs HRMY Comparison

GLP vs HRMY Comparison

Compare GLP & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$42.04

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$26.91

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
HRMY
Founded
2005
2017
Country
United States
United States
Employees
4700
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GLP
HRMY
Price
$42.04
$26.91
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$46.00
$46.70
AVG Volume (30 Days)
37.0K
625.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
7.17%
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
$64.13
$19.75
Revenue Next Year
$11.74
$12.88
P/E Ratio
$23.28
$9.92
Revenue Growth
N/A
21.51
52 Week Low
$39.58
$25.52
52 Week High
$56.59
$40.87

Technical Indicators

Market Signals
Indicator
GLP
HRMY
Relative Strength Index (RSI) 24.90 33.76
Support Level $40.13 $25.71
Resistance Level $45.74 $28.99
Average True Range (ATR) 1.55 0.72
MACD -0.59 0.17
Stochastic Oscillator 14.33 20.99

Price Performance

Historical Comparison
GLP
HRMY

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: